Six-Month Dispensing (6MMD)

Collected here are papers, policy briefs, and presentations about six-month dispensing of antiretrovirals and other medications from AMBIT, Retain6, and related projects.

Ntjikelane V, et al. Healthcare providers’ experiences with multmonth dispensing in Malawi and Zambia. AMBIT Policy Brief, December 4, 2025.

Mutanda N, et al. Client perspectives on six-month dispensing of antiretroviral therapy (ART) in South Africa. AMBIT Policy Brief, August 14, 2025.

Ntjikelane V, Huber A, Morgan A, Pascoe S, Manganye M, Malala L, Rosen S. Primary healthcare providers’ perspectives on six-month dispensing of HIV medication in South Africa: a cross-sectional survey. Global Health Action 2025; 18(1).

Jo Y, Rosen S, Nichols BE, Jamieson L, Lekodeba N, Horsburgh CR. Integrated multi-month dispensing for HIV and hypertension in South Africa: a model of epidemiological impact and cost-effectiveness. JIAS 2025: 28:e26413.

Shumba K, Mokhele I, Kachingwe E, Jamieson L, Fox MP, Rosen S, Tchereni T, Phiri W, Ngoma S, Nyerenda R, Pascoe S, Huber A. Impact of 6-monthly ART dispensing on retention in Malawi: a target trial emulation study. Abstract 1363. CROI 2025, San Franscisco, March 2025.

Hoffman RM, Moyo C, Balakasi K, Siwale Z, Hubbard J, Bardon A, Fox MP, Kakwesa G, Kalua T, Haambokoma M, Dovel K, Campbell P, Tseng C, Pisa TP, Cele R, Gupta S, Benade M, Long L, Xulu T, Sanne I, Rosen S. Multi-month dispensing of up to six months of antiretroviral therapy in Malawi and Zambia: Results of a cluster-randomized trial. Lancet Global Health 2021; 9: E628-E638. (Research supported by USAID/PEPFAR under EQUIP.)